Previous Close | 10.00 |
Open | 9.83 |
Bid | 9.50 x N/A |
Ask | 10.50 x N/A |
Day's Range | 9.50 - 10.50 |
52 Week Range | 6.50 - 18.50 |
Volume | |
Avg. Volume | 322,161 |
Market Cap | 12.172M |
Beta (5Y Monthly) | 0.13 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 |
Earnings Date | Mar 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 78.00 |
Abingdon Health PLC (AIM:ABDX) CEO and co-founder Chris Yates discusses the company's interim results and business operations in an interview with Proactive's Stephen Gunnion.
Abingdon Health ( LON:ABDX ) First Half 2024 Results Key Financial Results Revenue: UK£2.41m (up 117% from 1H 2023...